COMPARISON OF THE EFFECT OF INSULIN GLULISINE TO INSULIN ASPART ON BREAKFAST POSTPRANDIAL BLOOD GLUCOSE LEVELS IN CHILDREN WITH TYPE 1 DIABETES MELLITUS ON MULTIPLE DAILY INJECTIONS

Objective: Rapid-acting insulins, including insulin aspart (NovoLog) and lispro (Humalog), do not seem to effectively control postprandial glycemic excursions in children with type 1 diabetes mellitus (T1DM). The objective of this study was to determine if insulin glulisine (Apidra), another rapid-acting insulin analog, would be superior in controlling postprandial hyperglycemia in children with T1DM. Methods: Thirteen prepubertal children ages 4 to 11 years completed this study. Inclusion criteria included T1DM >= 6 months, glycosylated hemoglobin (HbA1C) 6.9 to 10%, blood glucose (BG) levels in adequate control for 1 week prior to study start, multiple daily injections (MDI) with insulin glargine or determir once daily and aspart or lispro premeal. If fasting BG was 70 to 180 mg/dL, subjects received insulin glulisine alternating with aspart prior to a prescribed breakfast with a fixed amount of carbohydrate (45, 60, or 75 g) for 20 days. Postprandial BG values were obtained at 2 and 4 hours. Results: Mean baseline BG values for insulin glulisine (136.4 +/- 15.7 mg/dL; mean +/- SD) and aspart (133.4 +/- 14.7 mg/dL) were similar (P = .34). Mean increase in 2-hour postprandial BG was higher in glulisine (+ 113.5 +/- 65.2 mg/dL) than aspart (+ 98.6 +/- 66.9 mg/dL), (P = .01). BG remained higher at 4 hours (glulisine: 141.9 +/- 36.5 mg/dL, aspart: 129.0 +/- 37.0 mg/dL) (P = .04). Although statistically insignificant, more hypoglycemic events occurred at 2- and 4-hours postprandial with insulin aspart. Conclusion: Insulin aspart appears to be more effective than insulin glulisine in controlling 2- and 4-hour postprandial BG excursions in prepubertal children with T1DM.